Product Program year 2025 Source: CMS Open Payments

Alinity

Device Core Diagnostics

PDI 00380740137380

Open in the dashboard

General payments

$56,165

331 payments

Research payments

$17,507

1 payment

Through program year 2025, $56,165 in general payments and $17,507 in research payments were reported against Alinity (Core Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2025 General $4,339 84
2024 General $24,008 143
2023 General $15,953 22
2023 Research $17,507 1
2022 General $11,864 82

Breakdown

Who paid General payments · program years 2022–2025
  1. Abbott Laboratories $56,165 331 payments
Top recipients General payments · program year 2025
  1. Deepak Mohan Anatomic Pathology & Clinical Pathology · French Camp, CA $2,228 51% · 5 payments
  2. Ravindra Sarode Blood Banking & Transfusion Medicine · Dallas, TX $208 5% · 3 payments
  3. Daniel Kirchoff Surgical Oncology · Charleston, SC $130 3% · 1 payment
  4. Kirthi Kumar Hematology · Dallas, TX $121 3% · 1 payment
  5. Nelson Ploch Urology · North Charleston, SC $119 3% · 1 payment

The top 5 of 71 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Anatomic Pathology & Clinical Pathology Pathology $2,951 69% · 31 practitioners
  2. Blood Banking & Transfusion Medicine Pathology $208 5% · 1 practitioner
  3. Hematology Pathology $137 3% · 2 practitioners
  4. Urology $137 3% · 2 practitioners
  5. Surgical Oncology Surgery $130 3% · 1 practitioner

The top 5 of 23 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $2,484 57% · 11 recipients
  2. Texas $602 14% · 16 recipients
  3. South Carolina $249 6% · 2 recipients
  4. Ohio $193 4% · 7 recipients
  5. Tennessee $109 3% · 3 recipients

The top 5 of 25 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

331 general · 1 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record